In fact, in breast cancer patients lower CXCL12 expression levels correlated with worse prognosis, mirrored by higher levels of the ligand detected in breast cancer cell lines with a lower metastatic potential [18,19]. This evidence concerns the gene CXCL12 and breast carcinoma.